植込み型心臓モニター市場：適応症別、エンドユーザー別、地域別、2026年～2032年

植込み型心臓モニター市場の評価、2026年～2032年

植込み型心臓モニター市場は、心血管疾患の有病率の増加とモニタリング技術の進歩に伴って開拓が進んでいます。これらのデバイスは継続的な心臓リズムの追跡を可能にし、不整脈の早期発見と治療に役立ち、患者の転帰を改善し、市場の成長を後押しします。これにより、市場規模は2024年に5億8,065万米ドルを突破し、2032年には8億5,788万米ドルに達する見込みです。

北米は、高いヘルスケア支出と近代的な医療インフラによって市場を独占しています。低侵襲技術の利用が増加しているため、欧州もかなりのシェアを占めています。新興市場は、改良された心臓モニタリング技術に対する認識と利用可能性が高まるにつれて急速に拡大しています。植込み型心臓モニターに対する需要の高まりは、2026年から2032年までのCAGR 5%での市場成長を可能にしています。

植込み型心臓モニター市場定義/概要

植込み型心臓モニターは、心臓のリズムを継続的にモニターして異常なパターンを検出し、不整脈やその他の心臓疾患の診断と治療のための情報を提供する、皮膚の下に装着する小型で長期的な装置です。

植込み型心臓モニターは、心臓のリズムを継続的にモニターし、異常を検出し、不整脈などの障害を診断します。このモニターは、リアルタイムのデータを提供し、長期的なモニタリングを支援し、原因不明の症状や慢性心疾患を持つ患者の治療法を調整するのに役立ちます。

植込み型心臓モニターは、心臓リズムの連続的なリアルタイム・モニタリングを可能にし、不整脈や心臓病の早期診断を向上させる。その用途は、個別化医療、遠隔患者管理、長期的な心血管系治療成績の向上に拡大すると思われます。

心臓不整脈の増加は植込み型心臓モニター市場の成長を促進するか？

心臓不整脈の増加は植込み型心臓モニター産業の原動力となると思われます。CDCによると、心房細動は65歳未満の約2％、65歳以上の約9％が罹患しており、2030年までに米国で1,200万人以上がこの病気に罹患すると予測されています。

さらに、もう一つの不整脈である心室細動では、毎年約30万人が死亡しています。このような病気の患者が増えるにつれ、植込み型心臓モニターのような連続モニタリング・ソリューションの需要も増えると思われます。これらの機器は不整脈の早期発見と制御に不可欠であり、拡大する患者数を管理するための効果的な方法をヘルスケア従事者が探しているため、市場拡大の原動力となっています。

デバイスと処置の高コストは植込み型心臓モニター市場の妨げになるか？

植込み型心臓モニターとそれに付随する処置のコストが高いことが、市場拡大を制限する可能性があります。米国では平均コストが4,000～5,000ドルであるため、特に保険未加入者や保険未加入者のアクセスや導入が制限される可能性があります。また、高額なコストはヘルスケアシステムや患者に経済的なプレッシャーを与え、機器の使用頻度を低下させる可能性があります。

さらに、ヘルスケアに携わる医師によっては、どうしても必要な場合を除き、このようなモニターを勧めないこともあります。しかし、技術開発、保険適用の改善、持続的心臓モニタリングの利点に関する知識の普及により、長期的にはこれらのハードルが緩和され、高価格にもかかわらず市場の成長が促進される可能性があります。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 植込み型心臓モニター市場：適応症別

• 心臓不整脈
• 心房細動（AFib）
• てんかんと原因不明の転倒

第5章 植込み型心臓モニター市場：エンドユーザー別

• 病院および診療所
• 在宅環境
• 外来手術センター

第6章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第7章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第8章 競合情勢

• 主要企業
• 市場シェア分析

第9章 企業プロファイル

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• LivaNova PLC
• MicroPort Scientific Corporation
• Angel Medical Systems, Inc.
• Medico S.p.A.
• Nuvectra Corporation
• Oscor Inc.

第10章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第11章付録

• 略語リスト
• 出典と参考文献

Implantable Cardiac Monitor Market Valuation - 2026-2032

The implantable cardiac monitor market is developing as the prevalence of cardiovascular illness increases and monitoring technology advances. These devices allow continuous cardiac rhythm tracking, which aids in the early detection and treatment of arrhythmias, improving patient outcomes and boosting market growth. This is likely to enable the market size surpass USD 580.65 Million valued in 2024 to reach a valuation of around USD 857.88 Million by 2032.

North America dominates the market, driven by high healthcare spending and modern medical infrastructure. Europe also have a considerable stake, because to increasing use of minimally invasive techniques. Emerging markets are quickly expanding as awareness and availability to improved cardiac monitoring technology increase. The rising demand for Implantable Cardiac Monitor is enabling the market grow at a CAGR of 5% from 2026 to 2032.

Implantable Cardiac Monitor Market: Definition/ Overview

An implantable cardiac monitor is a small, long-term device that is put beneath the skin to continually monitor heart rhythms and detect aberrant patterns, providing information for diagnosing and treating arrhythmias and other cardiac problems.

Implantable cardiac monitors continuously monitor heart rhythms, detecting anomalies and diagnosing disorders such as arrhythmia. They provide real-time data, assistance in long-term monitoring and assist in tailoring therapy for patients with unexplained symptoms or chronic cardiac disease.

Implantable cardiac monitors will allow for continuous, real-time monitoring of heart rhythms, improving early diagnosis of arrhythmias and heart diseases. Their applications will grow in personalised medicine, remote patient management and enhancing long-term cardiovascular care results.

Will Increasing Prevalence of Cardiac Arrhythmias Drive the Implantable Cardiac Monitor Market Growth?

The rising occurrence of cardiac arrhythmias will drive the implantable cardiac monitor industry. According to the CDC, atrial fibrillation affects around 2% of those under 65 and 9% of those over 65, with forecasts showing that more than 12 million people in the United States would have this illness by 2030.

Additionally, ventricular fibrillation, another arrhythmia, kills approximately 300,000 people each year. As the number of patients with these illnesses increases, so will the demand for continuous monitoring solutions like implantable cardiac monitors. These devices are critical for early identification and control of arrhythmias, which is driving market expansion as healthcare practitioners look for effective methods to manage an expanding patient base.

Will High Cost of Devices and Procedures Hamper the Implantable Cardiac Monitor Market?

The high cost of implantable cardiac monitors and accompanying procedures may limit market expansion. In the United States, the average cost ranges between $4,000 and $5,000, which may limit access and adoption, particularly among uninsured or underinsured patients. High costs can also put a financial pressure on healthcare systems and patients, thereby lowering the frequency of device use.

Furthermore, it may prevent some healthcare doctors from recommending these monitors unless absolutely essential. However, technological developments, improved insurance coverage and more knowledge of the benefits of continuous cardiac monitoring may alleviate these hurdles in the long run, thereby encouraging market growth despite the high price.

Category-Wise Acumens

Will High Prevalence and Significant Impact on Patient Health Drive the Indication Segment?

The increasing prevalence and serious consequences of cardiac arrhythmias will push the indication sector for implantable cardiac monitors. Atrial fibrillation is a condition that affects millions of people worldwide and is linked to serious health risks such as stroke and heart failure. This high incidence creates a significant demand for continuous monitoring technologies that can effectively manage and minimize these hazards.

The enormous health impact stresses the importance of early identification and intervention, which increases the usage of implantable cardiac monitors. As a result, the focus on cardiac arrhythmias remains a key driver of market expansion, as healthcare professionals seek innovative technology to address the widespread and critical nature of these disorders, thereby improving patient outcomes and treatment.

Will Growing Focus on Patient Convenience Bolster the End-User Segment?

The end-user segment of the implantable cardiac monitor market is expected to grow due to a greater emphasis on patient convenience. As healthcare systems and practitioners promote patient-centered care, there is an increasing desire for devices that are simple to use, cause less discomfort and enable continuous monitoring with fewer trips to healthcare facilities. Implantable cardiac monitors offer great convenience by enabling real-time, remote monitoring of heart problems without the need for frequent in-person check-ups.

This move toward patient convenience encourages wider use of these devices, which improve treatment adherence and overall patient happiness. Furthermore, technological developments such as wireless data transfer and better battery life make these devices more convenient and appealing, increasing their application in a variety of healthcare settings.

Country/Region-wise Acumens

Will High Prevalence of Cardiac Conditions Drive the Market in North America?

The rising prevalence of heart disorders will propel the implantable cardiac monitor market in North America. The region, notably the United States, have a high prevalence of disorders such atrial fibrillation, heart failure and ventricular arrhythmias, which require constant monitoring for optimal care. The increasing incidence increases the demand for improved monitoring technologies to improve patient outcomes and manage chronic illnesses.

Furthermore, the advanced healthcare infrastructure, significant expenditures in medical technology and supportive regulatory environment in North America all contribute to market growth. As the population ages and cardiovascular disorders become more frequent, the need for implantable cardiac monitors is likely to grow, confirming North America's market dominance.

Will Increasing Healthcare Investments Drive the Market in Asia Pacific Region?

Increasing healthcare investment will drive the Asia-Pacific implantable cardiac monitor market. Governments and the business sector are increasing healthcare resources to improve infrastructure, access and quality of care, including new medical technologies. This initiative promotes the use of implantable cardiac monitors by improving healthcare facilities and boosting availability of these devices.

Furthermore, greater knowledge of cardiovascular illnesses and an aging population drive demand. As healthcare systems in nations like as China and India improve, they become better equipped to provide cutting-edge technology, contributing to significant market expansion. The focus on improving healthcare services and increasing access to novel treatments guarantees that the Asia-Pacific region remains a key driver of market growth.

Competitive Landscape

The implantable cardiac monitor market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the implantable cardiac monitor market include:

Medtronic plc

Abbott Laboratories

Boston Scientific Corporation

BIOTRONIK SE & Co. KG

LivaNova PLC

MicroPort Scientific Corporation

Angel Medical Systems, Inc.

Medico S.p.A.

Nuvectra Corporation

Oscor, Inc.

Implantable Cardiac Monitor Market Latest Developments

In October 2023, Boston Scientific Corporation launched the LUX-Dx I+ cardiac monitor system. This device monitors arrhythmias associated with cryptogenic stroke, AFib and syncope for extended periods of time.

In June 2023, Biotronik announced the first implant of the BIOMONITOR IV. This implantable cardiac device. The monitor combines SmartECG technology with Al, which helps reduce false positive detections by 86%.

Implantable Cardiac Monitor Market, By Category

• Indication:
• Cardiac Arrhythmias
• Atrial Fibrillation
• Epilepsy and Unexplained Falls
• End-User:
• Ambulatory Surgical Centers (ASCs)
• Hospitals and Clinics
• Home Settings
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Implantable Cardiac Monitor Market, By Indication

• Cardiac arrhythmias
• Atrial fibrillation (AFib)
• Epilepsy & unexplained falls

5. Implantable Cardiac Monitor Market, By End User

• Hospitals and clinics
• Home settings
• Ambulatory surgical centers

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• LivaNova PLC
• MicroPort Scientific Corporation
• Angel Medical Systems, Inc.
• Medico S.p.A.
• Nuvectra Corporation
• Oscor Inc.

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References